| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PALISADE BIO, INC. | Chief Medical Officer | Restricted Stock Units | 7,665,800 | $0 | $4.76 | 06 Oct 2025 | Direct |
| PALISADE BIO, INC. | Chief Medical Officer | Phantom Units | 289,000 | 04 Sep 2025 | Direct | ||
| PALISADE BIO, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 29,000 | 11 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PALI | PALISADE BIO, INC. | 06 Oct 2025 | 1 | $0 | 4 | Chief Medical Officer | 08 Oct 2025, 17:41 |
| PALI | PALISADE BIO, INC. | 04 Sep 2025 | 1 | $0 | 4 | Chief Medical Officer | 05 Sep 2025, 09:00 |
| PALI | PALISADE BIO, INC. | 11 Feb 2025 | 2 | $0 | 4 | Chief Medical Officer | 13 Feb 2025, 17:58 |
| PALI | PALISADE BIO, INC. | 28 May 2024 | 6 | -$6,050 | 4 | Chief Medical Officer | 30 May 2024, 19:44 |
| PALI | PALISADE BIO, INC. | 06 May 2024 | 6 | -$1,159 | 4 | CEO, CFO, Director | 08 May 2024, 18:37 |
| PALI | PALISADE BIO, INC. | 21 Nov 2023 | 2 | $0 | 4 | Chief Medical Officer | 24 Nov 2023, 16:00 |
| PALI | PALISADE BIO, INC. | 06 Nov 2023 | 3 | -$878 | 4 | Chief Medical Officer | 08 Nov 2023, 17:01 |
| PALI | PALISADE BIO, INC. | 05 Sep 2023 | 0 | $0 | 3 | Chief Medical Officer | 13 Sep 2023, 18:20 |
| PALI | PALISADE BIO, INC. | 06 Feb 2023 | 5 | -$939 | 4 | Chief Medical Officer | 08 Feb 2024, 16:38 |